Table 1. Clinical characteristics of 14 patients diagnosed with confirmed maturity-onset diabetes of the young (MODY).
|
No |
MODY gene |
Age at diagnosis (year) |
Gender |
Family history for MODY/generations |
Clinical presentation |
HbA1c % level at diagnosis |
Follow-up treatment |
|
1 |
GCK |
14.2 |
Male |
+/3 |
Hyperglycaemia |
6.3 |
Diet |
|
2 |
GCK |
6.9 |
Male |
+/3 |
Hyperglycaemia |
6.6 |
Diet |
|
3 |
GCK |
7.5 |
Male |
+/2 |
Hyperglycaemia |
6.4 |
Diet |
|
4 |
GCK |
14.3 |
Male |
+/3 |
Hyperglycaemia |
6.3 |
Diet |
|
5 |
GCK |
7.1 |
Male |
+/3 |
Hyperglycaemia |
6.5 |
Diet |
|
6 |
GCK |
8.4 |
Female |
+/3 |
Hyperglycaemia |
6.3 |
Diet |
|
7 |
GCK |
6.1 |
Male |
+/3 |
Hyperglycaemia |
6.2 |
Diet |
|
8 |
GCK |
10.4 |
Male |
NA |
Hyperglycaemia |
6.8 |
Diet |
|
9 |
GCK |
17.8 |
Female |
+/3 |
Hyperglycaemia |
6.2 |
Diet |
|
10 |
GCK |
3.8 |
Female |
-/1 |
Hyperglycaemia |
6.3 |
Diet |
|
11 |
GCK |
8.5 |
Female |
+/2 |
Hyperglycaemia |
6.8 |
Diet |
|
12 |
HNF1B |
9.5 |
Male |
+/2 |
Diabetic ketoacidosis Multicystic kidneys |
8.8 |
Insulin |
|
13 |
HNF1B |
13,5 |
Female |
+/3 |
Diabetic ketoacidosis Multicystic kidneys |
9.8 |
Insulin |
|
14 |
ABCC8 |
3.5 |
Female |
+/2 |
Hyperglycaemia |
7.6 |
Sulfonylurea |
OADs: oral antidiabetic drugs, NA: not available